Influenza

Disease State Hub

News
Research Summaries
Resources
FDA Alerts From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes

FDA Alerts

FDA Approval
FDA sign
FDA Approval
FDA Approves mFLUSIVA for Influenza Prevention in Adults Aged 50 Years and Older
08/07/2026
Anthony Calabro, MA
The FDA approved an mRNA-based influenza vaccine mFLUSIVA for adults aged 50 years and older, with accelerated approval applying to adults aged 65 years and older.
08/07/2026
FDA Alert
FDA building
FDA Alert
FDA Limits COVID-19 Vaccine Access to People 65 and Older, High-Risk Populations
05/20/2025
Kate Young
The FDA has announced that it will limit access to COVID-19 vaccines, making them only available to high-risk populations. The organization also announced that they will require manufacturers to further...
05/20/2025
FDA Alert
nasal spray
FDA Alert
FDA Approves First Self-Administered Nasal Spray Influenza Vaccine
09/27/2024
Anthony Calabro, MA
The nasal spray is the first vaccine for the prevention of influenza that does not need to be administered by a health care provider.
09/27/2024
FDA alert
fda
FDA alert
FDA Approves the First RSV Vaccine For Use in United States
05/04/2023
Jessica Ganga
After an ongoing study, the FDA approves the first vaccine for the highly contagious respiratory virus for us in the United States.
05/04/2023
Influenza
Influenza
FDA: New Influenza Treatment
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
Influenza
Influenza
FDA Approves Generic Oral Suspension For Influenza
09/18/2017
The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.
09/18/2017